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1. Introduction 
The emergence of multi-drug resistant organisms has increasingly become a global public 
health issue. Rational and appropriate uses of antibiotics as well as strict infection control 
measurements are recommended in order to reduce the emergence of antibiotic resistant 
bacteria (Tseng et al., 2011). The complexity in treating multi-drug resistant infections has 
led to an increase in the search for novel and effective antibiotics, especially structures 
originating from natural products. Promising molecules could serve as lead compounds to 
be developed and researched further. 
This chapter aims to review the susceptibility of two of the most common micro-organisms 
that are often implicated in antibiotic resistant infections, namely the Gram-positive 
Staphylococcus aureus and Gram-negative Klebsiella pneumoniae against natural products, 
specifically plants. Numerous researchers have investigated the susceptibility of these bacteria 
to plant extracts as well as to the individual components thereof. Flavonoids as a group of 
compounds originating from natural products have been investigated against these bacteria. 
Flavonoids are diverse polyphenolic compounds which are widely distributed in the plant 
kingdom. They are abundantly found in natural sources like fruits, vegetables, seeds, nuts, 
flowers, tea, wine honey and propolis and therefore form part of the normal diet of humans 
(Cook & Samman, 1996). Many reports claim the usefulness of flavonoids in medical conditions, 
including anti-inflammatory, oestrogenic, antimicrobial, antioxidant and chelating, vascular 
and antitumour activities (Cook & Samman, 1996; Cushnie & Lamb, 2005). Flavonoids consist of 
a C15 skeleton composed of two phenolic rings, namely the A and B rings linked through a 
heterocyclic ring, C. They are classified according to their biosynthetic origin into major classes 
including flavones, flavonols, flavanones, chalcones, flavanols, anthocyanidins, isoflavones and 
dihydroflavonols. Substitution patterns vary and some flavonoids occur as glycosides which are 
hydrolysed in the human gut to the aglycones. Flavonoids also occur as monomers, dimers or 
oligomers (Cook & Samman, 1996; Cushnie & Lamb, 2005). 
Many reports exist on the antimicrobial activity of flavonoids (Basile et al., 2010; Du Toit et al., 
2009; Tanaka et al., 2011). Extracts as well as isolated compounds were tested against a 
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comprehensive panel of micro-organisms. Methods of assessing the activity include different 
diffusion and dilution methods. However, many flavonoids are insoluble in water and will 
thus have a low rate of diffusion in an aqueous medium such as agar, leading to inaccurate 
results. Therefore, only results based on dilution methods will be considered and discussed. 
Extracts are complex mixtures of many chemical compounds in different ratios and the 
results of such studies are not contributing to the understanding of the activity of specific 
flavonoids. Studies that investigated the antibacterial activity of individual flavonoids 
isolated from natural products will be reviewed instead. 
Various parameters have been used to express the antimicrobial activity of flavonoids. The 
minimum inhibitory concentration (MIC) will be considered and values up to 50 µg/ml will 
be reported. It must be appreciated that varying laboratory conditions and technical skills 
will have an influence on published results generated by different research groups and used 
in this review. The question also arises whether flavonoids exhibit bactericidal or 
bacteriostatic activity. Although some studies suggest that flavonoids are capable of 
bactericidal activity, the interpretation of the results remains inconclusive and it has been 
suggested that bacterial aggregates may be formed, thereby reducing the number of colony 
forming units in viable counts (Cushnie & Lamb, 2005). 
2. Staphylococcus aureus 
Staphylococcus aureus has long been recognised as an important pathogen in many diseases, 
for example the toxic shock syndrome, vasculitis and glomerulonephritis. The bacterium is 
commonly found in the nose and upper respiratory tract, locations that play an important 
role in the epidemiology and pathogenesis of infection. Therapy of infection has become 
problematic due to an increasing number of methicillin-resistant strains (MRSA). The 
difference between MRSA and methicillin-susceptible strains is that MRSA is resistant to β-
lactamase stable β-lactam antibiotics. Often this is also associated with resistance to many 
other antibiotics, which limits the therapeutic options. The prevalence of MRSA has also 
increased world-wide and new therapeutic agents, optimisation of infection control 
measures and introduction of new medical devices with a reduced risk of infection are being 
investigated (Kluytmans et al., 1997). 
3. Klebsiella pneumoniae 
Klebsiella pneumoniae is being considered the most common causative pathogen for infections 
caused by antibiotic-resistant bacteria. The rate of resistance to carbapenems has increased 
to more than 25% in the European Union in 2009 (Tseng et al., 2011). The nasopharynx and 
gastrointestinal tract are commonly colonised by the bacterium and it is well known to 
cause community-acquired bacterial pneumonia, occurring particularly in chronic alcoholics 
and showing characteristic radiographic abnormalities due to severe pyogenic infection 
which has a high fatality rate if untreated. It is an opportunistic pathogen that would most 
likely attack immunocompromised patients who are hospitalised and suffer from severe 
underlying diseases such as diabetes mellitus and chronic pulmonary obstructive diseases. 
The three most common conditions caused by Klebsiella spp. are urinary tract infections, 
septicaemia and wound infections. Septicaemia is particularly problematic in premature 
infants and patients in intensive care units (Podschun & Ullmann, 1998). 
The Susceptibility of Staphylococcus aureus and  
Klebsiella pneumoniae to Naturally Derived Selected Classes of Flavonoids 
 
75 
4. Occurrence of flavonoids in plant sources 
Several studies have identified flavonoids in natural products. Many flavonoid-containing 
plants are used therapeutically for the treatment of a variety of non-microbial illnesses as 
well as microbial infections. Flavonoids were derived from different parts of the plant and 
tested against S. aureus and K. pneumoniae. The vast number of identified compounds in 
studies were limited to cases where antibacterial activity was measured by means of 
dilution methods and where susceptibility was up to 50 µg/ml, providing a workable 
approach. At least 44 different compounds were identified according to the criteria, listed in 
Table 1 and their properties reviewed (Tables 2-7). 
 
Plant/Product Traditional Use Part Compound Reference 
Erythrina costaricensis
Micheli (Leguminosae)
Microbial infections Stems 1 Tanaka et al., 2009 
Erythrina costaricensis
Micheli (Leguminosae)
Microbial infections Stems 2 Tanaka et al., 2009 
Erythrina poeppigiana
(Leguminosae) 
Microbial infections Roots 3 Tanaka et al., 2004 
Erythrina poeppigiana
(Leguminosae 
Microbial infections Roots 4 Tanaka et al., 2004 
Brazilian red propolis 
Inflammation, 
heart disease, 
diabetes, cancer 
 5 Oldoni et al., 2011 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 6 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 7 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 8 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 9 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 10 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 11 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 12 Tanaka et al., 2002 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 13 Tanaka et al., 2002 
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Plant/Product Traditional Use Part Compound Reference 
Erythrina variegata 
(Leguminosae) 
Microbial 
infections, 
inflammation 
Roots 14 Tanaka et al., 2002 
Erythrina variegata
(Leguminosae) 
Microbial infections Roots 15 Tanaka et al., 2011 
Erythrina variegata
(Leguminosae) 
Microbial infections Roots 16 Tanaka et al., 2011 
Cycas circinalis
(Cycadaceae) 
Purgative Leaflets 17 Moawad et al., 2010 
Cycas circinalis
(Cycadaceae) 
Purgative Leaflets 18 Moawad et al., 2010 
Cycas revoluta Thumb 
(Cycadaceae) 
Rheumatic fever, 
expectorant, 
astringent, 
flatulence, 
vomiting, 
oestrogen-
dependent cancer 
Leaflets 19 Moawad et al., 2010 
Feijoa sellowiana Berg 
(Myrtaceae) 
Perfume, microbial 
infections, 
inflammation, 
cancer 
Fruits 20 Basile et al., 2010 
Lonchocarpus 
minimiflorus (Noctuidae)
Microbial infections Bark 21 Salvatore et al., 1998 
Viscum album ssp. album 
(Loranthaceae) 
Hypertension, 
epilepsy, 
exhaustion, 
anxiety, arthritis, 
vertigo, 
degenerative 
inflammation of the 
joints, cancer 
Leaves 
and stems
22 Orhan et al., 2010 
Viscum album ssp. album 
(Loranthaceae) 
Hypertension, 
epilepsy, 
exhaustion, 
anxiety, arthritis, 
vertigo, 
degenerative 
inflammation of the 
joints, cancer 
Leaves 
and stems
23 Orhan et al., 2010 
Galium fissurense 
Ehrend. & Schönb.-Tem. 
(Rubiaceae) 
Diuretic, 
astringent, gastro-
intestinal 
conditions, gout, 
epilepsy 
Leaves 
and stems
24 Orhan et al., 2010 
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Plant/Product Traditional Use Part Compound Reference 
Galium fissurense 
Ehrend. & Schönb.-Tem. 
(Rubiaceae) 
Diuretic, 
astringent, gastro-
intestinal 
conditions, gout, 
epilepsy 
Leaves 
and stems
25 Orhan et al., 2010 
Cirsium hypoleucum DC. 
(Asteraceae) 
Haemorrhoids, 
peptic ulcers, 
cough, bronchitis 
Aerial 
parts 
26 Orhan et al., 2010 
Cirsium hypoleucum DC. 
(Asteraceae) 
Haemorrhoids, 
peptic ulcers, 
cough, bronchitis 
Aerial 
parts 
27 Orhan et al., 2010 
Artocarpus sepicanus 
(Moraceae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever 
Leaves 28 Radwan et al., 2009 
Erythrina zeyheri 
(Leguminosae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever
Roots 29 Tanaka et al., 2003 
Erythrina zeyheri 
(Leguminosae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever
Roots 30 Tanaka et al., 2003 
Erythrina zeyheri 
(Leguminosae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever
Roots 31 Tanaka et al., 2003 
Erythrina zeyheri 
(Leguminosae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever
Roots 32 Tanaka et al., 2003 
Erythrina zeyheri 
(Leguminosae) 
Microbial 
infections, asthma, 
tuberculosis, 
rheumatic fever
Roots 33 Tanaka et al., 2003 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 34 Tsuchiya et al., 1996 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 35 Tsuchiya et al., 1996 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 36 Tsuchiya et al., 1996 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 37 Tsuchiya et al., 1996 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 38 Tsuchiya et al., 1996 
Sophora exigua Criab 
(Leguminosae)
Microbial infections Roots 39 Tsuchiya et al., 1996 
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Plant/Product Traditional Use Part Compound Reference 
Echinosophora koreensis
Nakai (Leguminosae)
Microbial infections Roots 40 Tsuchiya et al., 1996 
Echinosophora koreensis
Nakai (Leguminosae)
Microbial infections Roots 41 Tsuchiya et al., 1996 
Echinosophora koreensis
Nakai (Leguminosae)
Microbial infections Roots 42 Tsuchiya et al., 1996 
Echinosophora koreensis
Nakai (Leguminosae)
Microbial infections Roots 43 Tsuchiya et al., 1996 
Sophora leachiana Peck 
(Leguminosae)
Microbial infections Roots 44 Tsuchiya et al., 1996 
Table 1. Compounds isolated from different parts of plants/products that occur world-wide 
and their traditional use. Only compounds tested against Staphylococcus aureus and Klebsiella 
pneumoniae by means of dilution methods where the MIC-values were up to 50 µg/ml are 
reported (refer to Tables 2-7 where the classification, chemistry and biological activity of 
each compound are explained in more detail). 
5. Flavonoids and bacterial susceptibility 
The flavonoids identified in different plants/products which were investigated for their 
antibacterial activity using dilution methods, were divided into 6 structural types and the 
susceptibility of S. aureus and K. pneumoniae reviewed. Some of the strains of S. aureus were 
MSRA. 
Structural types were used in order to compare similar structures and to determine the 
influence of substituents on these structures. Susceptibility was also compared where the 
methods were similar to reduce the presence of too many variables. 
Compounds 17-19 (Table 6), which are biflavonoids, exhibited the weakest activity against 
S. aureus in comparison with all the other structures. This may be attributed to the size and 
stereochemistry of the molecules. The compounds exhibiting the highest activity were 
compounds 16 (Table 3) and 21 (Table 2), which interestingly share the same substitution 
pattern at R1 and R2 (which were substituted with a γ,γ-dimethylallyl and hydroxyl group 
respectively). Comparison of compounds 3, 6 and 16 (Table 3), which were all substituted 
with a γ,γ-dimethylallyl group at R5, showed that the addition of an extra γ,γ-dimethylallyl 
group influences activity. Addition at R3 increases activity and addition at R1 has an even 
more pronounced effect in the structural group. Comparison of compounds 30 and 31 (Table 
2) showed that substitution at R5 with a hydroxyl group leads to better activity than 
substitution with a methoxy group in the specific structural group. 
O
O
R1
R2
R3
R4
R10
R5
R6
R7
R8
R9
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Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
1 
R2,R4,R6=OH
R3,R8=γ,γ-dimethylallyl 
R7=OCH3
3.13-6.25* ND 
2 
R2,R3=2”,2” dimethylpyran
R4,R6=OH 
R7=OCH3 
R8=γ,γ-dimethylallyl 
12.5- >50* ND 
5 
R2,R5=OH
R7=OCH3 (3S-enantiomer)
31.2-62.5 ND 
8 
R2,R3=2”,2” dimethylpyran
R5,R7=OH (3R-enantiomer)
12.5-25* ND 
12 
R1,R2=2”,2” dimethylpyran
R3=γ,γ-dimethylallyl 
R7,R9=OH
3.13-12.5* ND 
15 
R1=γ,γ-dimethylallyl 
R2,R3=2”,2” dimethylpyran 
R7,R9,R10=OH
12.5-25* ND 
21 
R1,R3=γ,γ-dimethylallyl 
R2,R4,R6=OH (2S-enantiomer)
0.78-1.56* ND 
22 
R2,R4=OCH3 
R6=O-glc
4 16 
23 
R2,R4=OCH3 
R6=O-[2”-O-(5”’-O-trans-cinnamoyl)-β-D-
apiofuranosyl]-β-D-glucopyranoside
4 16 
24 
R2,R4,R5=OH
R6=O-glc
4 16 
25 
R4,R6=OH
R2=O-glc
4 16 
28 
R2,R4,R6=OH
R3=geranyl (2S-enantiomer)
1.23* ND 
29 
R1,R8=γ,γ-dimethylallyl 
R2,R7,R9=OH
12.5-25* ND 
30 
R1,R3=γ,γ-dimethylallyl 
R2,R7=OH 
R5=OCH3 (3R-enantiomer)
25- >50 ND 
31 
R1,R3=γ,γ-dimethylallyl 
R2,R5,R7=OH (3R-enantiomer)
3.13-6.25* ND 
32 
R1=γ,γ-dimethylallyl 
R2,R3=2”,2”-dimethylpyran 
R5,R7=OH
6.25-12.5* ND 
Table 2. Isoflavanones of the following structure isolated from plants and propolis 
(compound 5) and their activities against Staphylococcus aureus (*denotes MRSA strains) and 
Klebsiella pneumoniae. ND, not determined. 
A study by Du Toit and co-workers reported little activity of the flavonoids luteolin, 
eriodictyol and quercetin against S. aureus and MIC-values could not be determined. These 
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flavonoids are commonly found in propolis (Du Toit et al., 2009). Combinations of 
flavonoids at different concentrations as well as other components present in the propolis 
could account for its antimicrobial activity. 
Compared to S. aureus, it is noteworthy that significantly fewer compounds have been 
tested against K. pneumoniae. Compounds 22-25 (Table 2) and 20, 26-27 (Table 7) were the 
only compounds tested using dilution methods. Out of the few compounds tested, 
compound 20 showed the highest activity and it also has the least number of substituents. 
Future research should investigate the activity of more compounds against K. pneumoniae. 
New drug targets in the bacterial structure are important. Drugs will be less susceptible to 
resistance if it has several modes of action. Pharmacokinetic parameters such as 
bioavailability and plasma protein binding are also important, since successful traditional 
use indicates that the drug has successfully reached a specific target. 
 
O
O
R1
R2
R3
R5
R4
 
 
 
 
Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
3 
R2,R4=OH 
R5=γ,γ-dimethylallyl
12.5* ND 
4 
R2=OH 
R4=OCH3 
R5=γ,γ-dimethylallyl
12.5-25 ND 
6 
R2,R4=OH 
R3,R5=γ,γ-dimethylallyl
3.13-6.25* ND 
9 
R2=OH 
R4=OCH3 
R5=γ,γ-dimethylallyl
12.5-25* ND 
16 
R1,R5=γ,γ-dimethylallyl 
R2,R4=OH
1.56-3.13* ND 
 
Table 3. Isoflavonoids of the following structure isolated from plants and their activities 
against Staphylococcus aureus (*denotes MRSA strains) and Klebsiella pneumoniae. ND, not 
determined. 
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O
O
R2
R3
R4R5
OH
H
R1
 
 
Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
7 
R2=OH 
R3,R5=γ,γ-dimethylallyl 
R4=OCH3 
12.5-25* ND 
14 
R2,R4=OH 
R3,R5=γ,γ-dimethylallyl 
6.25-12.5* ND 
33 
R1,R5=γ,γ-dimethylallyl 
R2=OH 
R4=OCH3 (6aS, 11aS-enantiomer) 
6.25-25* ND 
Table 4. Isoflavonoids of the following structure isolated from plants and their activities 
against Staphylococcus aureus (*denotes MRSA strains) and Klebsiella pneumoniae. ND, not 
determined. 
O
O
R1
R2
R3R4
H
H
 
 
Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
10 
R1=OCH3 
R2=γ,γ-dimethylallyl 
R3=OH RR 
3.13-6.25* ND 
11 
R1,R2=2”,2”-dimethylpyran 
R3=OH 
R4=γ,γ-dimethylallyl 
6.25-25* ND 
13 
R1=OH 
R3,R4=2”,2”-dimethylpyran 
25* ND 
Table 5. Isoflavonoids of the following structure isolated from plants and their activities 
against Staphylococcus aureus (*denotes MRSA strains) and Klebsiella pneumoniae. ND, not 
determined. 
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O
O
HO
OH O
R1
HO OH
O
R2
 
 
Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
17 R1,R2=OCH3 (2S, 2’’S-enantiomer) 17.5* ND 
18 
R1=OCH3 
R2=OH (2S, 2’’S-enantiomer)
35.9* ND 
19 R1,R2=OH (2S-enantiomer) 37* ND 
Table 6. Biflavonoids of the following structure isolated from plants and their activities 
against Staphylococcus aureus (*denotes MRSA strains) and Klebsiella pneumoniae. ND, not 
determined. 
O
O
R1
R2
R3
R4
R5
R6
R7
R8
R9
 
 
Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
20 R5=OH 7.8 7.8 
26 
R2,R4,R6,R7=OH 
R9=O-glc-rha
4 16 
27 
R2,R4,R7=OH 
R9=O-glc-rha
4 16 
34 
R1=lavandulyl 
R2,R4,R7,R8=OH
3.13-6.25* ND 
35 
R1=lavandulyl 
R2,R4,R5,R8=OH 
R3=prenyl 
R7=OCH3
3.13-6.25* ND 
36 R1=prenyl 6.25* ND 
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Compound Structure 
Susceptibility (MIC, µg/ml) 
S. Aureus K. Pneumoniae 
R2,R4,R5,R8=OH 
R7=OCH3
37 
R1=lavandulyl 
R2,R4,R5,R8=OH
12.5* ND 
38 
R2,R4,R5,R7,R8=OH 
R3=geranyl
12.5* ND 
39 
R1=geranyl 
R2,R4,R5,R7,R8=OH
>25* ND 
40 
R2,R4,R7,R8= OH 
R6=geranyl
3.13-12.5* ND 
41 
R2,R4,R5,R7,R8=OH 
R3=lavandulyl
3.13-12.5* ND 
42 
R1=lavandulyl 
R2,R4,R5,R7,R8=OH
6.25-12.5* ND 
43 
R2,R4,R7,R8=OH 
R1=prenyl
6.25-12.5* ND 
44 
R1=lavandulyl 
R2,R4,R8=OH
12.5* ND 
Table 7. Flavones of the following structure isolated from plants and their activities against 
Staphylococcus aureus (*denotes MRSA strains) and Klebsiella pneumoniae. ND, not determined. 
6. Conclusion 
The traditional use of medicinal plants is useful as a guideline in the quest for new drugs. 
Furthermore plants are a source of novel lead compounds which would generally not have 
been synthesised. Extraction of these biologically active lead compounds may be expensive 
and slow and the activity of lead compounds may also not be sufficient to encourage 
commercialisation. These compounds may also have undesirable side effects, it is therefore 
important to periodically review the results of research conducted, ruling out unnecessary 
variation of parameters, to determine the most promising structures. The process of drug 
design and development could then be accelerated. 
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